SP-D is produced predominantly by type II pneumocytes; its expression is correlated with pulmonary function and is increased in stable COPD (3), with higher levels observed during acute exacerbation (4,5). The gene discussed is SFTPD; the disease is chronic obstructive pulmonary disease.